|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | A61K 31/40 | (2006.01) |
| A61K 9/22 | (2006.01) | ||
| A61K 9/24 | (2006.01) |
| (11) | Number of the document | 1898904 |
| (13) | Kind of document | T |
| (96) | European patent application number | 06772653.9 |
| Date of filing the European patent application | 2006-06-08 | |
| (97) | Date of publication of the European application | 2008-03-19 |
| (45) | Date of publication and mention of the grant of the patent | 2009-10-07 |
| (46) | Date of publication of the claims translation | 2010-01-25 |
| (86) | Number | PCT/US2006/022416 |
| Date | 2006-06-08 |
| (87) | Number | WO 2006/135723 |
| Date | 2006-12-21 |
| (30) | Number | Date | Country code |
| 689719 P | 2005-06-10 | US | |
| 690309 P | 2005-06-14 | US |
| (72) |
KOWALSKI, James, US
LAKSHMAN, Jay, Parthiban, US
SERAJUDDIN, Abu, T. M., US
JOSHI, Yatindra, US
|
| (73) |
Novartis AG,
Lichtstrasse 35, 4056 Basel,
CH
|
| (74) |
Marius JAKULIS - JASON,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Modifikuoto atpalaidavimo 1-[(3-hidroksi-adamant-1-ilamino)-acetil]-pirolidin-2(S)-karbonitrilo kompozicija |
| MODIFIED RELEASE 1-[(3-HYDROXY-ADAMANT-1-YLAMINO)-ACETYL]-PYRROLIDINE-2(S)-CARBONITRILE FORMULATION |
| Payment date | Validity (years) | Amount | |
| 2017-05-30 | 12 | 289.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2018-06-08 |